SRGCX Performance — Stringer Tactical Adaptive Risk Fund (formerly Stringer Growth Fund), Class C
Data updated: 2026-01-28
SRGCX returned +6.62% over one year to Nov 2025. Annualised returns are +8.35% over 3 years and +5.07% over 5 years. The fund trailed its US Multi-Cap Blend category average: $100 invested three years ago grew to $127, against $138 for the category, and to $107 over one year, against $109. Volatility over the past three years was 9.39% a year. In the 12 months to Nov 2025 the fund lost a net $4.1M, and assets reached $21.17M.
SRGCX Growth of $100
What $100 invested in Stringer Tactical Adaptive Risk Fund (formerly Stringer Growth Fund) grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Multi-Cap Blend category average over the same months.
| Period | SRGCX | Category average |
|---|---|---|
| 1 year (Dec 2024 – Nov 2025) | $107 | $109 |
| 3 years (Dec 2022 – Nov 2025) | $127 | $138 |
| 5 years (Dec 2020 – Nov 2025) | $128 | $140 |
| Since data start (Mar 2020 – Nov 2025) | $151 | $160 |
SRGCX Trailing Returns
Total returns to Nov 2025, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +6.62% |
| 3 years (annualised) | +8.35% |
| 5 years (annualised) | +5.07% |
SRGCX Annual Returns
Calendar-year total returns of Stringer Tactical Adaptive Risk Fund (formerly Stringer Growth Fund), compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2025 (Jan–Nov) | +11.36% |
| 2024 | +7.07% |
| 2023 | +11.09% |
| 2022 | −19.70% |
| 2021 | +16.20% |
| 2020 (Mar–Dec) | +22.43% |
SRGCX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | +2.8% | +0.2% | −3.6% | −0.2% | +3.0% | +3.0% | −0.1% | +2.2% | +3.0% | +1.2% | −0.4% | — |
| 2024 | +1.5% | +2.9% | +2.0% | −3.7% | +3.3% | +1.1% | +0.9% | +1.5% | +0.9% | −2.3% | +3.4% | −4.3% |
| 2023 | +5.0% | −3.0% | +2.1% | +1.5% | −1.6% | +3.6% | +1.5% | −1.7% | −3.5% | −1.9% | +6.4% | +2.8% |
| 2022 | −5.4% | −2.6% | +2.4% | −8.1% | +0.6% | −8.8% | +5.9% | −3.9% | −7.6% | +6.2% | +5.3% | −4.0% |
| 2021 | −0.7% | +3.4% | +2.7% | +3.5% | +2.1% | +0.3% | +0.3% | +1.7% | −3.9% | +4.2% | −2.0% | +3.9% |
| 2020 | — | — | −12.1% | +8.8% | +5.4% | +1.8% | +4.1% | +5.1% | −2.7% | −2.2% | +10.4% | +3.6% |
SRGCX Risk
Risk measures from monthly returns over Dec 2022 – Nov 2025.
- 3-year volatility (annualised): 9.39%
- 3-year Sharpe ratio: 0.41 (vs 4.5% risk-free rate)
- Best month: +6.38% (Nov 2023)
- Worst month: −4.26% (Dec 2024)
SRGCX Fund Flows
Monthly money in and out of Stringer Tactical Adaptive Risk Fund (formerly Stringer Growth Fund), from SEC Form N-PORT.
- 12-month net flow: −$4.1M
- 12-month gross sales (incl. reinvestments): $3.0M
- Sales ÷ redemptions: 0.43×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Nov 2025 | $109K | $1.1M | −$977K |
| Oct 2025 | $360K | $811K | −$451K |
| Sep 2025 | $16K | $1.0M | −$989K |
| Aug 2025 | $173K | $728K | −$555K |
| Jul 2025 | $193K | $1.2M | −$986K |
| Jun 2025 | $9K | $207K | −$198K |
| May 2025 | $60K | $194K | −$134K |
| Apr 2025 | $1.2M | $407K | $827K |
| Mar 2025 | $83K | $365K | −$282K |
| Feb 2025 | $110K | $398K | −$287K |
| Jan 2025 | $349K | $474K | −$125K |
| Dec 2024 | $333K | $256K | $77K |
SRGCX Assets Under Management
Net assets of Stringer Tactical Adaptive Risk Fund (formerly Stringer Growth Fund) by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2025-11-30 | $21.17M |
| 2025-08-31 | $22.71M |
| 2025-05-31 | $23.25M |
| 2025-02-28 | $22.91M |
| 2024-11-30 | $23.86M |
| 2024-08-31 | $23.43M |
| 2024-05-31 | $23.32M |
| 2024-02-29 | $23.96M |
| 2023-11-30 | $22.63M |
| 2023-08-31 | $24.47M |
| 2023-05-31 | $25.45M |
| 2023-02-28 | $24.66M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.